Author(s):
Shruti Ranjitbhai Patel, Bhoomi S. Patel, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar
Email(s):
anuradha@ssgsalvav.in
DOI:
10.52711/2231-5691.2025.00010 
Address:
Shruti Ranjitbhai Patel1*, Bhoomi S. Patel2, Anuradha Prajapati2, Sachin Narkhede2, Shailesh Luhar2
1Smt. B.N.B Swaminarayan Pharmacy College, Gujarat Technological University, Salvav, Vapi, Gujarat, India, 396191.
2Department of Pharmaceutics, Smt. BNB Swaminarayan Pharmacy College, Gujarat Technological University, Salvav, Vapi, Gujarat, India, 396191.
*Corresponding Author
Published In:
Volume - 15,
Issue - 1,
Year - 2025
ABSTRACT:
The aim of Nanomedicines for infectious disease, particularly through the use of potential nanocarriers, is to apply nanotechnology for the prevention and treatment of illnesses within the human body. In later a long time, critical exertion has been coordinated to create nanotechnology for medicate conveyance gadgets since it offers a appropriate implies of conveying small-molecule drugs, as well as biomacromolecules such as proteins, peptides, or oligonucleotides by either localized or focused on conveyance to cells and tissues of intrigued. Until presently, lipid-, polymer-, or nano-/microparticle-based sedate conveyance frameworks (DDS) have been created to make strides the adequacy and decrease the systemic harmfulness of a wide extend of drugs. A few DDS details of anticancer drugs, antifungal drugs, and immunizations are affirmed for clinical utilize. In this chapter, we will primarily center on the clinical utilize of DDS on treatment and anticipation of irresistible illnesses. The plausibility of applying nanomaterials to the conclusion, treatment, and anticipation of illnesses makes nanomedicine one of the most appealing ranges of nanotechnology. The application of nanomaterials in atomic imaging, sedate conveyance, and restorative mediations guarantees to have a positive affect in this range owing to the interesting properties of nanoparticles, which will permit them to overcome cellular and physiological obstructions. Nanomedicine is an developing field of restorative nanotechnology that utilizes nanoparticles with antioxidative properties to effectively moderate down maturing forms caused by oxidative stretch and irritation. Nanomedicine leverages nanocarriers for the treatment of irresistible illnesses, advertising exact, successful, and inventive arrangements. These nanocarriers, such as liposomes, polymeric nanoparticles, and metallic nanoparticles, upgrade sedate conveyance by focusing on contaminated cells, making strides medicate solvency, and giving controlled discharge, hence diminishing side impacts and optimizing helpful impacts. Also, they empower combination treatment, overcoming sedate resistance by conveying different operators straightforwardly to pathogens.
Cite this article:
Shruti Ranjitbhai Patel, Bhoomi S. Patel, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar. Nanomedicines for Infectious Disease: Potential Nanocarriers. Asian Journal of Pharmaceutical Research. 2025; 15(1):60-4. doi: 10.52711/2231-5691.2025.00010
Cite(Electronic):
Shruti Ranjitbhai Patel, Bhoomi S. Patel, Anuradha Prajapati, Sachin Narkhede, Shailesh Luhar. Nanomedicines for Infectious Disease: Potential Nanocarriers. Asian Journal of Pharmaceutical Research. 2025; 15(1):60-4. doi: 10.52711/2231-5691.2025.00010 Available on: https://asianjpr.com/AbstractView.aspx?PID=2025-15-1-10
REFERENCES:
1. Priyadharshini S, Dhivya B. Application of Nanoscience and Technology in Medicine-Nanomedicine. Research Journal of Engineering and Technology. 2013; 4(4): 300-5.
2. Verma C, Janghel A, Deo S, Raut P, Bhosle D, Kumar SS, Agrawal M, Amit N, Sharma M, Giri T, Tripathi DK. A comprehensive advancement on nanomedicines along with its various biomedical applications. Research Journal of Pharmacy and Technology. 2015; 8(7): 945-57.
3. Navnath NS, Sahebrao NU. Nanomedicines: Nano based Drug Delivery Systems Challenges and Future of nanomedicines. Asian Journal of Pharmacy and Technology. 2024; May 27; 14(2): 135-40.
4. Kumar R, Jha AK, Jain SK. Nanomedicine: An Emerging Area of Nanotechnology. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009; 1(1): 18-21.
5. Irvine DJ, Dane EL. Enhancing cancer immunotherapy with nanomedicine. Nature Reviews Immunology. 2020; May; 20(5): 321-34.
6. Martin JD, Cabral H, Stylianopoulos T, Jain RK. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nature reviews Clinical Oncology. 2020; Apr; 17(4): 251-66.
7. Bregoli L, Movia D, Gavigan-Imedio JD, Lysaght J, Reynolds J, Prina-Mello A. Nanomedicine applied to translational oncology: A future perspective on cancer treatment. Nanomedicine: Nanotechnology, Biology and Medicine. 2016; Jan 1; 12(1): 81-103.
8. Freitas RA. Nanomedicine, volume I: basic capabilities. Georgetown, TX: Landes Bioscience. 1999 Jan.
9. Somwanshi S, Dola R, Siddheshwa S, Mereka A, Godg R, Patta S. Nanomedicine drug delivery system. J. Asian J. Biomed. Pharm. Sci. 2013; Aug 10; 3: 9-15.
10. Robert A, Freitas Jr JD. What is nanomedicine. Nanomed. Nanotechnol. Biol. Med. 2005; 1: 2-9.
11. Coombs RR, Robinson DW. Nanotechnology in Medicine and the Biosciences. (No Title). 1996.
12. Khamkar G, Moon R, Mali D, Kale A, Likhe R. Nanomedicine: as a novel application of nanotechnology. International Journal of Pharmaceutical Sciences and Research. 2011; Jun 1; 2(6): 1389.
13. Boulaiz H, Alvarez PJ, Ramirez A, Marchal JA, Prados J, Rodríguez-Serrano F, Perán M, Melguizo C, Aranega A. Nanomedicine: application areas and development prospects. International Journal of Molecular Sciences. 2011; May 19; 12(5): 3303-21.
14. Zhang C, Yan L, Wang X, Zhu S, Chen C, Gu Z, Zhao Y. Progress, challenges, and future of nanomedicine. Nano Today. 2020; Dec 1; 35: 101008.
15. Jackman JA, Lee J, Cho NJ. Nanomedicine for infectious disease applications: innovation towards broad‐spectrum treatment of viral infections. Small. 2016; Mar;12(9): 1133-9.
16. Baldino L. Nanosomes in Precision Nanomedicine. Nanomaterials. 2024; 14(21): 1717.
17. Celia C, Teesalu T, Santos HA. Unlocking the potential of nanomedicine: advances in precision targeting strategies. Drug Delivery and Translational Research. 2024; Oct; 14(10): 2593-7.